We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Guidance on Shedding Studies for Bacteria-Based Drugs
FDA Finalizes Guidance on Shedding Studies for Bacteria-Based Drugs
September 10, 2015
Biologics makers developing drugs based on bacteria and viruses should conduct preclinical and clinical studies to determine if infection could be unintentionally transmitted from treated patients to other individuals, the FDA says.